Nonproprietary Naming of Biological Products Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 12, 2017
April 27, 2020
2c820442-8476-4109-a13c-a42550929546
Related Documents
Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling-Final
Guidance DocumentDecember 12, 2017Center for Drug Evaluation and Research
Individual Patient Expanded Access Applications: Form FDA 3926
Guidance DocumentOctober 3, 2017Center for Drug Evaluation and Research
Formal Dispute Resolution: Sponsor Appeals Above the Division Level Guidance for Industry and Review Staff
Guidance DocumentMay 30, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.